Table 3.
Dermatological examination at baseline (t0) and after 2 months of treatment (t1) of two groups
| Group I t0 (N = 30) | Group II t0 (N = 30) | Group I t1 (N = 30) | Group II t1 (N = 30) | |
|---|---|---|---|---|
| Blackheads score | ||||
| Absent | 3.00 (10%) ± 0.31 | 6.00 (20%) ± 0.41 | 15.00 (50%) ± 0.51 | 14.00 (46.67%) ± 0.51 |
| Mild | 12.00 (40%) ± 0.50 | 14.00 (46.67%) ± 0.51 | 15.00 (50%) ± 0.51 | 13.00 (43.33%) ± 0.50 |
| Moderate | 14.00 (46.66%) ± 0.51 | 10.00 (33.3%) ± 0.48 | 0.00 (0%) ± 0.00 | 3.00 (10%) ± 0.31 |
| Severe | 1.00 (3.33%) ± 0.18 | 0.00 (0%) ± 0.00 | 0.00 (0%) ± 0.00 | 0.00 (0%) ± 0.00 |
| Whiteheads score | ||||
| Absent | 0.00 (0%) ± 0.00 | 3.00 (10%) ± 0.31 | 20.00 (66.67%) ± 0.48 | 15.00 (50%) ± 0.51 |
| Mild | 21.00 (70%) ± 0.47 | 20.00 (66.67%) ± 0.48 | 10.00 (33.33%) ± 0.48 | 12.00 (40%) ± 0.50 |
| Moderate | 7.00 (23.33%) ± 0.43 | 4.00 (13.33) ± 0.35 | 0.00 (0%) ± 0.00 | 3.00 (10%) ± 0.31 |
| Severe | 2.00 (6.67%) ± 0.25 | 2.00 (6.67%) ± 0.25 | 0.00 (0%) ± 0.00 | 0.00 (0%) ± 0.00 |
| Papules and pustules score | ||||
| Absent | 4.00 (13.33%) ± 0.35 | 6.00 (20%) ± 0.41 | 20.00 (66.67%) ± 0.48 | 16.00 (53.33%) ± 0.51 |
| Mild | 13.00 (43.33%) ± 0.5 | 13.00 (43.33%) ± 0.50 | 10.00 (33.33%) ± 0.48 | 6.00 (20%) ± 0.41 |
| Moderate | 13.00 (43.33%) ± 0.5 | 11.00 (36.67%) ± 0.49 | 0.00 (0%) ± 0.00 | 7.00 (23.33%) ± 0.43 |
| Severe | 0.00 (0%) ± 0.00 | 0.00 (0%) ± 0.00 | 0.00 (0%) ± 0.00 | 1.00 (3.33%) ± 0.18 |
| Erythema score | ||||
| Absent | 6.00 (20%) ± 0.41 | 7.00 (23.33%) ± 0.44 | 24.00 (80%) ± 0.41 | 14.00 (46.67%) ± 0.51 |
| Mild | 23.00 (76.67%) ± 0.43 | 13.00 (43.33%) ± 0.51 | 6.00 (20%) ± 0.41 | 13.00 (43.33%) ± 0.50 |
| Moderate | 1.00 (3.33%) ± 0.18 | 9.00 (30%) ± 0.47 | 0.00 (0%) ± 0.00 | 3.00 (10%) ± 0.31 |
| Severe | 0.00 (0%) ± 0.00 | 0.00 (0%) ± 0.00 | 0.00 (0%) ± 0.00 | 0.00 (0%) ± 0.00 |
| Desquamation score | ||||
| Absent | 13.00 (43.33%) ± 0.50 | 10.00 (33.33%) ± 1.83 | 26.00 (86.67%) ± 0.35 | 22.00 (73.33%) ± 0.45 |
| Mild | 12.00 (40%) ± 0.50 | 14.00 (46.67%) ± 0.51 | 4.00 (13.33%) ± 0.35 | 7.00 (23.33%) ± 0.43 |
| Moderate | 5.00 (16.67%) ± 0.38 | 4.00 (13.33%) ± 0.35 | 0.00 (0%) ± 0.00 | 1.00 (3.33%) ± 0.18 |
| Severe | 0.00 (0%) ± 0.00 | 1.00 (3.33%) ± 0.18 | 0.00 (0%) ± 0.00 | 0.00 (0%) ± 0.00 |
| Sebum score | ||||
| Absent | 2.00 (6.67%) ± 0.25 | 3.00 (10%) ± 0.31 | 18.00 (60%) ± 0.50 | 12.00 (40%) ± 0.50 |
| Mild | 12.00 (40%) ± 0.5 | 14.00 (46.67%) ± 0.51 | 11.00 (36.67%) ± 0.49 | 13.00 (43.33%) ± 0.50 |
| Moderate | 16.00 (53.33%) ± 0.51 | 13.00 (43.33%) ± 0.50 | 1.00 (3.33%) ± 0.18 | 5.00 (16.67%) ± 0.38 |
| Severe | 0.00 (0%) ± 0.00 | 0.00 (0%) ± 0.00 | 0.00 (0%) ± 0.00 | 0.00 (0%) ± 0.00 |
| Porphyrin production | ||||
| Mild | 22.00 (73.33%) ± 0.45 | 21.00 (70%) ± 0.47 | 8.00 (26.67%) ± 0.45 | 11.00 (36.67%) ± 0.49 |
| Moderate | 8.00 (26.67%) ± 0.45 | 7.00 (23.33%) ± 0.43 | 0.00 (0%) ± 0.00 | 3.00 (10%) ± 0.31 |
| Absent | 1.00 (3.33%) ± 0.18 | 2.00 (6.67%) ± 0.25 | 22.00 (73.33%) ± 0.45 | 16.00 (53.33) ± 0.51 |
Values in the table are presented as a subjects number with the percentage in parenthesis ± SD